Materias dentro de su búsqueda.
Mostrando 1,521 - 1,540 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 0.36s Limitar resultados
  1. 1521
    “…Emerging evidence implicates microbiome involvement in the development of pancreatic cancer (PaCa). Here, we investigate whether increases in circulating microbial-related metabolites associate with PaCa risk by applying metabolomics profiling to 172 sera collected within 5 years prior to PaCa diagnosis and 863 matched non-subject sera from participants in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cohort. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A blood-based metabolomic signature predictive of risk for pancreatic cancer
  2. 1522
    “…SLE-associated pancreatitis is uncommon, and pancreatic cancer in SLE is very rare. Imaging findings in SLE with pancreatitis can mimic malignancy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Lupus Pancreatitis Masquerading as Pancreatic Cancer: A Rare Clinical Presentation
  3. 1523
    “…Pancreatic cancer represents one of the most lethal cancer types worldwide, with a 5-year survival rate of less than 5%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Advances in Pancreatic Cancer Treatment by Nano-Based Drug Delivery Systems
  4. 1524
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells
  5. 1525
    “…To identify DEGs, genome RNA sequencing and clinical data from pancreatic cancer patients were extracted from The Cancer Genome Atlas Database (TCGA). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer
  6. 1526
    por Yu, Wenjing, Li, Mei, Xia, Jing
    Publicado 2023
    “…Targeting immunogenic cell death (ICD) may enable the response of pancreatic cancer to immune checkpoint inhibitors (ICIs). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Identification of immunogenic cell death‑related prognostic signatures in pancreatic cancer
  7. 1527
    por Sun, Yudi, He, Xinyi, Sun, Yan
    Publicado 2023
    “…BACKGROUND: The relationship between red and processed meat consumption and pancreatic cancer risk is controversial and no study has looked specifically at the correlation for 6 years. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Red and processed meat and pancreatic cancer risk: a meta-analysis
  8. 1528
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection
  9. 1529
    “…Despite modern advances in cancer medicine, pancreatic cancer survival remains unchanged at just 12%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The role of diagnostic, prognostic, and predictive biomarkers in the management of early pancreatic cancer
  10. 1530
    “…It is known to mimic pancreatic cancer due to its similar clinical and radiological presentations. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Obstructive Jaundice Mimicking Pancreatic Cancer: An Unusual Presentation of Autoimmune Pancreatitis
  11. 1531
    “…We used RNA-sequencing to compare 14 matched tumor and normal (tumor adjacent) pancreatic cancer samples and found Malassezia RNA in both the PDAC and normal tissues. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The inflammatory response of human pancreatic cancer samples compared to normal controls
  12. 1532
    “…This cohort study compares the outcomes of patients with BRCA1 and BRCA-related pancreatic cancers using 2 large data sets.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Analysis of BRCA1- and BRCA2-Related Pancreatic Cancer and Survival
  13. 1533
    “…Abnormal expression and activities of both cyclooxygenases and lipoxygenases have been reported in pancreatic cancer. In this article, we aim to provide a brief summary of (1) our understanding of the roles of these enzymes in pancreatic cancer tumorigenesis and progression; and (2) the potential of using cyclooxygenase and lipoxygenase inhibitors for pancreatic cancer treatment and prevention.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemoprevention of pancreatic cancer
  14. 1534
    por Ringel, Jörg, Löhr, Matthias
    Publicado 2003
    “…The early diagnosis of pancreatic cancer, as well as distinguishing between chronic pancreatitis and malignant pancreatic disease, remains still a clinical problem. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    The MUC gene family: Their role in diagnosis and early detection of pancreatic cancer
  15. 1535
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Palladin Mutation Causes Familial Pancreatic Cancer: Absence in European Families
  16. 1536
    Publicado 1992
    Enlace del recurso
    Texto
    Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer
  17. 1537
    “…We found immunodetectable p53 in 13 of 22 (60%) frozen pancreatic cancers and seven of 13 pancreatic cell lines. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.
  18. 1538
    “…The in vivo administration of somatostatin (SS) or its analogues is capable of suppressing the growth of pancreatic cancer in experimental animals. We examined the effects of SS-14 and its analogue RC-160 on the in vitro growth of two human pancreatic cancer cell lines MiaPaCa-2 and Panc-1 stimulated with epidermal growth factor (EGF) or insulin-like growth factor 1 (IGF-1). …”
    Enlace del recurso
    Enlace del recurso
    Texto
    Human pancreatic cancer cell lines do not express receptors for somatostatin.
  19. 1539
    “…We investigated the expression and release of CAM 17.1 in pancreatic carcinoma cell lines and tissue specimens of normal pancreas, chronic pancreatitis and pancreatic cancer. CAM 17.1 was weakly expressed on normal ductal cells and chronic pancreatitis, whereas it was overexpressed in pancreatic cancer. …”
    Enlace del recurso
    Enlace del recurso
    Texto
    CAM 17.1--a new diagnostic marker in pancreatic cancer.
  20. 1540
    “…The deoxycytidine analogue 2′,2′-difluoro-2′-deoxycytidine (dFdC, gemcitabine) is a potent radiosensitiser, but has limited efficacy in combination with radiotherapy in patients with pancreatic cancer due to acute toxicity. We investigated whether cyclopentenyl cytosine (CPEC), targetting the ‘de novo’ biosynthesis of cytidine triphosphate (CTP), could increase dFdC cytotoxicity alone or in combination with irradiation in a panel of human pancreatic cancer cells (Panc-1, Miapaca-2, BxPC-3). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells
Herramientas de búsqueda: RSS